Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05185739 |
| Title | Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) (PRIMER-1) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University College, London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Queen Elizabeth Hospital | Not yet recruiting | Birmingham | United Kingdom | Details | ||
| Cambridge University Hospitals NHS Foundation Trust | Not yet recruiting | Cambridge | United Kingdom | Details | ||
| Beatson West of Scotland Cancer Centre | Not yet recruiting | Glasgow | United Kingdom | Details | ||
| St James's Hospital, Leeds Teaching Hospital NHS Trust | Not yet recruiting | Leeds | United Kingdom | Details | ||
| Clatterbridge Cancer Centre | Not yet recruiting | Liverpool | United Kingdom | Details | ||
| King's College Hospital | Not yet recruiting | London | United Kingdom | Details | ||
| Royal Free Hospital | Recruiting | London | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | Not yet recruiting | Manchester | United Kingdom | Details | ||
| Northern Institute of Cancer Research | Not yet recruiting | Newcastle Upon Tyne | United Kingdom | Details |